Phase 3 Tuberculosis Clinical Trials
26 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 26 trials
Recruiting
Phase 3
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Acute Coronary SyndromeTuberculosisPulmonary Hypertension (Diagnosis)
National University Hospital, Singapore150 enrolled6 locationsNCT05473520
Recruiting
Phase 2Phase 3
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Tuberculosis, Latent
Johns Hopkins University2,530 enrolled6 locationsNCT06568484
Recruiting
Phase 3
Shortened Regimen for Drug-susceptible TB in Children
TuberculosisTuberculosis, PulmonaryMycobacterium Tuberculosis+1 more
Johns Hopkins University860 enrolled9 locationsNCT06253715
Recruiting
Phase 2Phase 3
Shorter and Safer Treatment Regimens for Latent TB
Tuberculosis Infection, Latent
McGill University Health Centre/Research Institute of the McGill University Health Centre1,800 enrolled14 locationsNCT06498414
Recruiting
Phase 3
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.532 enrolled35 locationsNCT07209761
Recruiting
Phase 2Phase 3
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
Latent Tuberculosis
Centers for Disease Control and Prevention3,400 enrolled21 locationsNCT03474029
Recruiting
Phase 3
Pragmatic Optimized Rifampicin Trial
Tuberculosis, Pulmonary
Radboud University Medical Center164 enrolled2 locationsNCT06057519
Recruiting
Phase 2Phase 3
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco400 enrolled6 locationsNCT06441006
Recruiting
Phase 3
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
TuberculosisLatent Tuberculosis
Huashan Hospital3,520 enrolled47 locationsNCT06022146
Recruiting
Phase 3
A PAN-USR TB Multi-Center Trial
Pulmonary Tuberculosis
Shenzhen Third People's Hospital610 enrolled3 locationsNCT06905522
Recruiting
Phase 3
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
TuberculosisHIV
Johns Hopkins University150 enrolled6 locationsNCT06497465
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
Tuberculosis
Chengdu CoenBiotech Co., Ltd1,784 enrolled8 locationsNCT07152639
Recruiting
Phase 3
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd450 enrolled2 locationsNCT05824871
Recruiting
Phase 3
Novel Triple-dose Tuberculosis Retreatment Regimen
multidrug-resistant tuberculosisTuberculosisPulmonary Tuberculosis+1 more
Institute of Tropical Medicine, Belgium370 enrolled1 locationNCT04260477
Recruiting
Phase 3
Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above
Latent Tuberculosis Infection
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.780 enrolled8 locationsNCT05899179
Recruiting
Phase 3
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
multidrug-resistant tuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital1,050 enrolled5 locationsNCT05081401
Recruiting
Phase 3
Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Pulmonary Tuberculosis
Kaohsiung Veterans General Hospital.270 enrolled8 locationsNCT06727864
Recruiting
Phase 3
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Tuberculosis
Biofabri, S.L7,120 enrolled1 locationNCT04975178
Recruiting
Phase 2Phase 3
DeMONSTRATE-TB Study in Ethiopia
Reducing Tuberculosis Incidence
Management Sciences for Health131,438 enrolled2 locationsNCT06719193
Recruiting
Phase 2Phase 3
Safety of Administering Isoniazid to SLE Patients to Prevent TB
TuberculosisSystemic Lupus Erythematosus
Universitas Padjadjaran60 enrolled1 locationNCT06618573